Advanz Pharma

Advanz Pharma company information, Employees & Contact Information

Explore related pages

Related company profiles:

Partner of choice in specialty, hospital, and rare disease medicines ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty, hospital, and rare disease medicines they depend on. Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients. Headquartered in London, UK, we have commercial sales in more than 90 countries globally and have a direct commercial presence in more than 20 countries, including key countries in Europe, the US, Canada, and Australia. Our Centre of Excellence in Mumbai, India, as well as an established global distribution and commercialisation partner network complement our global operations. ADVANZ PHARMA’s product portfolio and pipeline comprises innovative medicines, specialty generics & biosimilars, and originator brands. Our products and pipeline cover a broad range of therapeutic areas, including hepatology, gastroenterology, anti-infectives, critical care, endocrinology, CNS, and, more broadly, rare diseases. We can only achieve our ambition with the passion of our dedicated and highly qualified people, acting in line with our company values of entrepreneurship, speed, and integrity.

Company Details

Employees
680
Address
Dashwood House, 2nd Floor, 69 Old Broad Street,sweden
Phone
+46 (0) 42-13 57 70
Email
in****@****bcur.se
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
London, England
Looking for a particular Advanz Pharma employee's phone or email?

Advanz Pharma Questions

News

Advanz Pharma and Alvotech Announce EMA Acceptance of Marketing Authorization Application for Biosimilar AVT23 - Quiver Quantitative

Advanz Pharma and Alvotech Announce EMA Acceptance of Marketing Authorization Application for Biosimilar AVT23 Quiver Quantitative

Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe - GlobeNewswire

Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe GlobeNewswire

Alvotech and Advanz Pharma Announce Positive EMA Opinion for Gobivaz®, a Biosimilar to Simponi® - Quiver Quantitative

Alvotech and Advanz Pharma Announce Positive EMA Opinion for Gobivaz®, a Biosimilar to Simponi® Quiver Quantitative

ADVANZ PHARMA’s response to the reversal of the suspension - GlobeNewswire

ADVANZ PHARMA’s response to the reversal of the suspension GlobeNewswire

Alvotech's Xolair Biosimilar Achieves Major Milestone: 600-Patient Trial Shows Therapeutic Match - Stock Titan

Alvotech's Xolair Biosimilar Achieves Major Milestone: 600-Patient Trial Shows Therapeutic Match Stock Titan

ADVANZ PHARMA’s response to European Commission revocation of conditional marketing authorisation for OCALIVA® in rare disease Primary Biliary Cholangitis (PBC) - Yahoo Finance

ADVANZ PHARMA’s response to European Commission revocation of conditional marketing authorisation for OCALIVA® in rare disease Primary Biliary Cholangitis (PBC) Yahoo Finance

ADVANZ PHARMA makes key changes to senior leadership to further accelerate next phase of growth - PR Newswire

ADVANZ PHARMA makes key changes to senior leadership to further accelerate next phase of growth PR Newswire

European Commission Revokes Obeticholic Acid (Ocaliva) CMA for Primary Biliary Cholangitis - HCPLive

European Commission Revokes Obeticholic Acid (Ocaliva) CMA for Primary Biliary Cholangitis HCPLive

ADVANZ PHARMA Corp. Limited Closes Acquisition of Specialty Pharmaceutical Company Correvio Pharma Corp. - SEC.gov

ADVANZ PHARMA Corp. Limited Closes Acquisition of Specialty Pharmaceutical Company Correvio Pharma Corp. SEC.gov

Advanz Pharma Raises Funding From Ontario Teachers’ And Nordic Capital - Pulse 2.0

Advanz Pharma Raises Funding From Ontario Teachers’ And Nordic Capital Pulse 2.0

MHRA approves Advanz Pharma’s combined antibiotic to treat complicated infections - PMLiVE

MHRA approves Advanz Pharma’s combined antibiotic to treat complicated infections PMLiVE

Nordic Capital acquires ADVANZ PHARMA for $846m - PMLiVE

Nordic Capital acquires ADVANZ PHARMA for $846m PMLiVE

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant